Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-308

First 308 Last

Share
Profile

Follow
MickeyMantle536

933 Posts.

1446

11/03/22

20:21

Post #: 60147698
Share

Originally posted by olliesfield ↑

The p-value being above >0.05 is not ideal, this infers the results were not statistically significant and may well have been due to chance. This is why we need a larger sample size, the results and reductions are still promising however. Market most likely observed this and changed its tune a little bit, coupled with all the macro factors at the moment. I’m still holding and looking to top up next week, IMO as I stated before a few days ago, this drug will be positive for specific people at specific times, but not the ‘miracle drug’ for OSA. Very happy to be proven otherwise.

Expand

The p-value was 0.0067 for IHL-42X treatment periods, which is statistically relevant.

It means that the highly positive results did NOT occur by chance.

In other words, what you stated is incorrect.

Last edited by MickeyMantle536: 11/03/22

IHL Price at posting: 45.5¢ Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell wins first international approval for nerve repair product

LMS

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

DRO

Droneshield shares move up on $13.5M US govt contract

WAF

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

TMK

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

There are more pages in this discussion • 82 more messages in this thread...

First 308 Last

Add IHL (ASX) to my watchlist